Core Viewpoint - The company announced adjustments and delays to certain fundraising projects to improve the efficiency of fundraising usage while keeping the total amount unchanged [1][2]. Fundraising Basic Situation - The company raised a total of RMB 3,201,044,000 from its initial public offering, with a net amount of RMB 3,201,044,000 after deducting issuance costs [1]. Fundraising Investment Project Situation - The total investment amount for the projects is RMB 246,813.72 million, with the company planning to use the remaining over-raised funds of RMB 47,220.00 million for new projects [2]. - The company decided to allocate approximately RMB 20,183.60 million from remaining funds to the "Electronic Engineering Testing Center Construction Project," increasing its total investment from RMB 73,858.20 million to RMB 94,041.80 million [2]. Fundraising Usage Situation - As of June 30, 2025, the cumulative investment amount reached RMB 294,561.17 million, with RMB 206,546.28 million from the raised funds [4]. Adjustment of Fundraising Project Sub-items - The company adjusted the investment amounts for several projects, including increasing the investment for high-voltage BCD advanced process from RMB 6,500 million to RMB 14,000 million [4]. - The investment for the RiscV architecture SoC platform was reduced from RMB 4,800 million to RMB 2,000 million due to market conditions [4]. Delay of Fundraising Projects - The company plans to delay the expected completion date for the "Development and Technology Reserve Fund Project" from August 2025 to August 2026 [6]. - The delay is attributed to changes in the macro market environment, industry technology development, and the company's strategic adjustments [6]. Measures to Ensure Timely Completion - The company will closely monitor industry trends and market changes, optimize resource allocation, and strengthen project supervision to ensure timely completion of fundraising projects [7]. Impact of Project Delay - The delay is a prudent decision based on actual project progress and will not adversely affect the implementation of fundraising projects or harm shareholder interests [7][8].

Core Viewpoint - The company has completed the conclusion of certain fundraising projects and plans to permanently supplement its working capital with the remaining funds, while also terminating some fundraising projects and continuing to manage the remaining funds in a dedicated account [2][10]. Fundraising Basic Situation - The company raised a total of RMB 161,846.38 million from its initial public offering, with a net amount of RMB 153,596.90 million after deducting issuance costs [2][3]. - As of June 30, 2025, the company has invested RMB 101,216.57 million, representing 65.90% of the committed investment [3]. Fundraising Project Status - The "East China R&D and Technical Service Center Construction Project" has been concluded, with remaining funds of RMB 3,211.84 million to be used for working capital after settling outstanding payments [5][10]. - The "East China Machine Vision Industrial Park Construction Project" has been terminated due to delays in obtaining necessary permits and changes in market demand, with a total planned investment of RMB 30,659.78 million [5][10]. Project Termination Reasons - The termination of the "East China Machine Vision Industrial Park Construction Project" is attributed to the expansion of downstream product demand beyond the original project scope and the company's comprehensive product line upgrade [9][10]. - The project was initially planned to meet specific market needs, but the evolving market landscape has necessitated a reevaluation of the project’s viability [9][10]. Future Plans - The company intends to seek new investment projects while continuing to evaluate existing projects for potential additional investments [10]. - The remaining funds from the terminated project will continue to be managed in accordance with fundraising management requirements [10]. Internal Review Process - The board of directors and the supervisory board have approved the conclusion of certain fundraising projects and the management of remaining funds, ensuring compliance with relevant regulations [11][12]. Sponsor Institution Opinion - The sponsor institution supports the company's decisions regarding the conclusion and management of fundraising projects, affirming that these actions align with the company's operational realities and long-term strategy [12][13].

Meeting Details - The second meeting of the Supervisory Board of Suzhou Guangge Technology Co., Ltd. was held on July 23, 2025, with all three supervisors present, confirming the legality and validity of the meeting [1]. Cash Management Decisions - The Supervisory Board approved the use of up to RMB 280 million of temporarily idle raised funds for cash management, which is in compliance with relevant regulations and aims to enhance fund utilization efficiency and increase returns for the company and its shareholders [1]. - The Board also agreed to use up to RMB 150 million of temporarily idle self-owned funds for cash management, emphasizing that this will not adversely affect the company's normal operations or the interests of shareholders, particularly minority shareholders [2]. Adjustments to Investment Projects - The Supervisory Board consented to adjustments in the investment amounts and internal structure of certain fundraising projects, stating that these changes are based on objective circumstances and will not negatively impact the implementation of fundraising projects or the company's normal operations [3]. - This adjustment will be submitted for approval at the shareholders' meeting, with the Board affirming that it does not constitute a substantive change in the use of raised funds or harm shareholder interests [3].

Group 1 - The company is holding its first extraordinary general meeting of shareholders in 2025 to discuss various proposals, including the extension, termination, and addition of implementation content for fundraising projects [1][7] - The meeting will take place on July 29, 2025, at 14:00 in the company's conference room, with both on-site and online voting options available [6][14] - Shareholders and their representatives are required to register 30 minutes before the meeting and must present identification to participate in the voting process [2][3] Group 2 - The company plans to adjust its fundraising project timelines due to market conditions, including a slowdown in the semiconductor market and changes in customer demand [11][12] - The company has decided to terminate the "High-Precision PGA/ADC Signal Chain Chip Upgrade and Industrialization Project" due to unfavorable market conditions and the need to allocate resources more effectively [20][21] - The remaining funds from the terminated project will be kept in a special account and used for new projects that align with the company's strategic goals [22][30] Group 3 - The company intends to increase the implementation content of the "R&D Center Construction Project" to enhance its capabilities in mixed-signal SoC chip products and applications [23][26] - The company is focusing on developing smart home control chips as part of its strategic deployment in response to market trends and government policies promoting smart home technologies [28][29] - The adjustments made to the project are expected to optimize resource allocation and ensure the smooth implementation of fundraising projects without negatively impacting the company's operations [29][30] Group 4 - The company is proposing changes to its registered capital and profit distribution policy, as well as the cancellation of the supervisory board, to align with its operational needs and legal requirements [30][31] - The registered capital will be adjusted following the completion of the 2023 restricted stock incentive plan, increasing the total share capital significantly [31]

Group 1 - The company has decided to terminate certain fundraising projects after re-evaluation, which will not significantly impact its normal operations and aligns with its long-term development strategy [1][2][3] - The board of directors approved the termination of the "Research and Development Center Construction Project" during the 18th meeting of the 6th board on July 14, 2025, and the unused raised funds will remain in a dedicated account [1][4] - The supervisory board and independent directors have also reviewed and approved the decision, confirming that it complies with relevant regulations and does not harm the interests of the company or its shareholders [2][3][4] Group 2 - The company is undergoing a change in its corporate structure, including a change in company type and registered capital, as well as the cancellation of the supervisory board [23][24][29] - The registered capital will decrease from 252,241,516 yuan to 251,737,562 yuan due to stock option exercises and the cancellation of repurchased shares [24][28] - The company will no longer have a supervisory board, with its functions being transferred to the audit committee of the board of directors [29][30] Group 3 - The company plans to increase capital for its subsidiary, Changsha Botai Electronics Co., Ltd., and subsequently for its subsidiary, Luoding Yada Co., Ltd., to optimize their capital structure and support business development [46][47] - The capital increase for Botai Electronics will amount to 200 million yuan, raising its registered capital from 15,569,450 yuan to 215,569,450 yuan [47] - The capital increase for Luoding Yada will also be 200 million yuan, increasing its registered capital from 123,344,370.86 yuan to 323,344,370.86 yuan [47][48]

Fundraising Overview - The company raised a total of RMB 1,047,987,200.00 from the issuance of 16.64 million shares at a price of RMB 62.98 per share, with a net amount of RMB 920,537,016.65 after deducting issuance costs [1][2] - All raised funds have been deposited into a special account approved by the board of directors, and a tripartite supervision agreement has been signed with the sponsor and the supervising bank [2] Project Status - As of May 31, 2025, the company has invested RMB 19,993.20 million in the "Smart Health Medical ASSP Chip Upgrade and Industrialization Project," which represents 26.66% of the planned investment of RMB 75,000.00 million [2] - The company has been using its own funds and acceptance bills to pay for project-related expenses, with plans to replace these with raised funds in subsequent quarters [2] Project Delays - The company plans to adjust the expected completion dates for its fundraising projects due to the semiconductor market's cyclical adjustments and structural demand declines, as well as the rapid technological iterations in the industry [4][22] - The company has decided to delay the purchase of office space due to the overall downturn in the real estate market since 2022, opting to conduct project research and development in existing facilities [5] Project Necessity and Feasibility - The "Smart Health Medical ASSP Chip Upgrade and Industrialization Project" is deemed necessary due to the increasing importance of national health and the government's strategic push for health initiatives [6] - The project aligns with national policies promoting the health industry and is supported by local government initiatives, creating favorable conditions for implementation [6][12] Termination of Project - The "High-Precision PGA/ADC Signal Chain Chip Upgrade and Industrialization Project" is proposed to be terminated due to the unfavorable market conditions and the high competition in the semiconductor industry [13][14] - The remaining funds of RMB 15,284.06 million from the terminated project will be kept in the special account and used for new projects with strong profitability and growth potential [16] Adjustments to Project Implementation - The company plans to increase the scope of the "R&D Center Construction Project" to include the development of smart home control chips, reflecting a strategic shift towards the smart home market [19][20] - The implementation will now involve a wholly-owned subsidiary, Shenzhen Jinghua Zhixin Microelectronics Co., Ltd., to optimize resource allocation and ensure project success [17][19] Regulatory Compliance - The adjustments to the fundraising projects have been approved by the board and supervisory committee and will be submitted for shareholder approval, ensuring compliance with relevant regulations [21][24] - The company emphasizes that these changes will not adversely affect its normal operations or shareholder interests, aligning with its long-term strategic goals [22][23]

Meeting Overview - The first bondholders' meeting for "Heshun Convertible Bonds" will be held on July 14, 2025, at 15:00 in Hangzhou, Zhejiang Province [5][11] - The meeting aims to protect the legal rights of bondholders and ensure orderly proceedings [2][4] Bond Issuance and Fund Utilization - The company issued 3.38 million convertible bonds with a total amount of 338 million yuan, net proceeds amounting to 331.67 million yuan after expenses [7][10] - The original project "Annual Production of 124,000 Tons of Nylon New Materials" is being adjusted to "Annual Production of 50,800 Tons of Nylon New Materials" [11][15] Project Adjustment Details - The adjustment involves reallocating the previously raised funds, with 76.24 million yuan already utilized primarily for construction [11][12] - The new project will focus on producing various nylon products, including nylon 6 and nylon 66, with a total investment of 281.19 million yuan [15][18] Market and Industry Context - The nylon industry is experiencing rapid growth, with increasing demand for high-performance nylon products [19][20] - The company aims to enhance its product structure and market competitiveness by diversifying into higher-value nylon products [20][21] Future Prospects - The adjusted project is expected to achieve an internal rate of return of 21.36% after reaching full production [18] - The company is positioned to meet the growing market demand for nylon materials, particularly in high-end applications [19][20]

Core Viewpoint - Aojing Medical (688613) is undergoing adjustments to its fundraising projects, including changes in implementation subjects and locations, which are deemed necessary for the company's development and efficiency in using raised funds [1][2][3]. Company Announcements - Aojing Medical's second supervisory board meeting approved two resolutions: one regarding the postponement of certain fundraising projects, and the other concerning adjustments to the implementation subjects and locations of these projects [1][4]. - The company will hold its first extraordinary shareholders' meeting on July 11, 2025, to review the adjustments to the fundraising projects [1][4]. Fundraising Project Adjustments - As of December 31, 2024, Aojing Medical's fundraising projects include the Aojing Health Technology Industrial Park construction and other projects, with a total planned investment of 500.82 million yuan [2][3]. - The Aojing Health Technology Industrial Park construction project has been postponed from June 30, 2025, to June 30, 2027, due to strategic adjustments and the impact of national procurement policies [3]. - The company has canceled the implementation of the project by its subsidiary in Jiaxing and will return the remaining raised funds to its dedicated account [2].

Core Viewpoint - The company, 聚合顺新材料股份有限公司, is adjusting its fundraising project from an annual production capacity of 124,000 tons of nylon new materials to 50,800 tons, reflecting a strategic shift in production focus and capacity optimization [1][5][9]. Summary by Sections Project Adjustment Overview - The original project aimed for an annual production of 124,000 tons, including 104,000 tons of nylon 6 chips and 20,000 tons of copolymer nylon chips. The revised project will have a capacity of 50,800 tons, comprising 18,000 tons of nylon 6 copolymer chips, 14,000 tons of nylon 66 chips, 7,000 tons of nylon 66 copolymer chips, and 11,800 tons of modified nylon [1][8][12]. Funding and Financial Details - The company issued 3.38 million convertible bonds with a total amount of 338 million yuan, netting 331.67 million yuan after expenses. The bonds are set to be traded on the Shanghai Stock Exchange starting August 15, 2024 [2][3][12]. - The total investment for the new project is estimated at 281.19 million yuan, with 155.04 million yuan planned to be funded through the raised capital [8][12]. Reasons for Adjustment - The adjustment is driven by a reduced urgency for increasing nylon 6 chip production due to the anticipated release of production capacity from other projects. The company aims to focus on higher value-added products like copolymer nylon and nylon 66, which are expected to have broader market applications and enhance overall competitiveness [9][10][15]. - The company has already invested 76.24 million yuan in the original project, primarily in civil engineering, with a remaining balance of 78.80 million yuan [4][5][12]. Project Feasibility and Market Outlook - The project aligns with national policies supporting the nylon new materials industry, which is experiencing rapid growth. The company has established advanced production systems and a strong R&D team to support the new project [14][15]. - The expected internal rate of return for the project is 21.36%, with a payback period of 8.61 years [12][14]. Governance and Approval Process - The adjustments have been approved by the company's board and supervisory committee and will be submitted for shareholder and bondholder meetings for final approval [22][23][61].

Group 1 - The company held its 9th meeting of the 2nd Supervisory Board on June 26, 2025, with all three supervisors present, and the meeting was conducted in accordance with relevant laws and regulations [1][2] - The Supervisory Board approved a proposal to increase the investment amount for certain fundraising projects and to permanently supplement working capital with surplus raised funds, which aligns with the company's future operational development plans [1][2] - The voting results for the proposal were unanimous, with 3 votes in favor, 0 against, and 0 abstentions [2] Group 2 - The decision to adjust the investment total for the "Fluid Equipment Component Manufacturing Project" and conclude it was deemed beneficial for improving the efficiency of fund utilization and in the interest of the company and all shareholders [1] - The meeting's resolutions were documented and are available for review, ensuring transparency and compliance with regulatory requirements [2]